Name	Value
NAME	Immunocompromised Therapies
OID	2.16.840.1.113883.3.666.5.2348
SHORT ID	IT48
VERSION DATE	2017-01-06 00:00:00
CODE LIST	CODES: CODE DESCRIPTION: Radiation therapy procedure or service (procedure) CODE DESCRIPTION: Chemotherapy (procedure) CODES: CODE: 3E00X05 CODE DESCRIPTION: Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach CODE: 3E0300M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Peripheral Vein, Open Approach CODE: 3E0J70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Via Natural or Artificial Opening CODE: 3E0J805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic CODE: 3E0J80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic CODE: 3E0K305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach CODE: 3E0K30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Genitourinary Tract, Percutaneous Approach CODE: 3E0K705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening CODE: 3E0K70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Genitourinary Tract, Via Natural or Artificial Opening CODE: 3E0K805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic CODE: 3E0K80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic CODE: 3E0L305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach CODE: 3E0300P CODE DESCRIPTION: Introduction of Clofarabine into Peripheral Vein, Open Approach CODE: 3E0L30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Pleural Cavity, Percutaneous Approach CODE: 3E0L705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening CODE: 3E0L70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Pleural Cavity, Via Natural or Artificial Opening CODE: 3E0M305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach CODE: 3E0M30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Peritoneal Cavity, Percutaneous Approach CODE: 3E0M705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening CODE: 3E0M70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Peritoneal Cavity, Via Natural or Artificial Opening CODE: 3E0N305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach CODE: 3E0N30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Male Reproductive, Percutaneous Approach CODE: 3E0N705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening CODE: 3E03302 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach CODE: 3E0N70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Male Reproductive, Via Natural or Artificial Opening CODE: 3E0N805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic CODE: 3E0N80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Male Reproductive, Via Natural or Artificial Opening Endoscopic CODE: 3E0P305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach CODE: 3E0P30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Female Reproductive, Percutaneous Approach CODE: 3E0P705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening CODE: 3E0P70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Female Reproductive, Via Natural or Artificial Opening CODE: 3E0P805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic CODE: 3E0P80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Female Reproductive, Via Natural or Artificial Opening Endoscopic CODE: 3E0Q305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach CODE: 3E03303 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach CODE: 3E0Q30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Percutaneous Approach CODE: 3E0Q705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening CODE: 3E0Q70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Via Natural or Artificial Opening CODE: 3E0R302 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach CODE: 3E0R303 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach CODE: 3E0R305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach CODE: 3E0R30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Spinal Canal, Percutaneous Approach CODE: 3E0S302 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach CODE: 3E0S303 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach CODE: 3E0S305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach CODE: 3E03305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach CODE: 3E0S30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Epidural Space, Percutaneous Approach CODE: 3E0U305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Joints, Percutaneous Approach CODE: 3E0U30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Joints, Percutaneous Approach CODE: 3E0V305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Bones, Percutaneous Approach CODE: 3E0V30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Bones, Percutaneous Approach CODE: 3E0W305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach CODE: 3E0W30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Lymphatics, Percutaneous Approach CODE: 3E0Y305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach CODE: 3E0Y30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Pericardial Cavity, Percutaneous Approach CODE: 3E0Y705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening CODE: 3E0330M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Peripheral Vein, Percutaneous Approach CODE: 3E0Y70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Pericardial Cavity, Via Natural or Artificial Opening CODE: 3E0330P CODE DESCRIPTION: Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach CODE: 3E04002 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Central Vein, Open Approach CODE: 3E04003 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach CODE: 3E04005 CODE DESCRIPTION: Introduction of Other Antineoplastic into Central Vein, Open Approach CODE: 3E00X0M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Skin and Mucous Membranes, External Approach CODE: 3E0400M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Central Vein, Open Approach CODE: 3E0400P CODE DESCRIPTION: Introduction of Clofarabine into Central Vein, Open Approach CODE: 3E04302 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach CODE: 3E04303 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach CODE: 3E04305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach CODE: 3E0430M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Central Vein, Percutaneous Approach CODE: 3E0430P CODE DESCRIPTION: Introduction of Clofarabine into Central Vein, Percutaneous Approach CODE: 3E05002 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach CODE: 3E05003 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach CODE: 3E05005 CODE DESCRIPTION: Introduction of Other Antineoplastic into Peripheral Artery, Open Approach CODE: 3E01305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach CODE: 3E0500M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Peripheral Artery, Open Approach CODE: 3E0500P CODE DESCRIPTION: Introduction of Clofarabine into Peripheral Artery, Open Approach CODE: 3E05302 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach CODE: 3E05303 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach CODE: 3E05305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach CODE: 3E0530M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Peripheral Artery, Percutaneous Approach CODE: 3E0530P CODE DESCRIPTION: Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach CODE: 3E06002 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Central Artery, Open Approach CODE: 3E06003 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach CODE: 3E06005 CODE DESCRIPTION: Introduction of Other Antineoplastic into Central Artery, Open Approach CODE: 3E0130M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach CODE: 3E0600M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Central Artery, Open Approach CODE: 3E0600P CODE DESCRIPTION: Introduction of Clofarabine into Central Artery, Open Approach CODE: 3E06302 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach CODE: 3E06303 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach CODE: 3E06305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach CODE: 3E0630M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Central Artery, Percutaneous Approach CODE: 3E0630P CODE DESCRIPTION: Introduction of Clofarabine into Central Artery, Percutaneous Approach CODE: 3E09305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Nose, Percutaneous Approach CODE: 3E0930M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Nose, Percutaneous Approach CODE: 3E09705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening CODE: 3E02305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Muscle, Percutaneous Approach CODE: 3E0970M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Nose, Via Natural or Artificial Opening CODE: 3E09X05 CODE DESCRIPTION: Introduction of Other Antineoplastic into Nose, External Approach CODE: 3E09X0M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Nose, External Approach CODE: 3E0A305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach CODE: 3E0A30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Bone Marrow, Percutaneous Approach CODE: 3E0B305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Ear, Percutaneous Approach CODE: 3E0B30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Ear, Percutaneous Approach CODE: 3E0B705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening CODE: 3E0B70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Ear, Via Natural or Artificial Opening CODE: 3E0BX05 CODE DESCRIPTION: Introduction of Other Antineoplastic into Ear, External Approach CODE: 3E0230M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Muscle, Percutaneous Approach CODE: 3E0BX0M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Ear, External Approach CODE: 3E0C305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Eye, Percutaneous Approach CODE: 3E0C30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Eye, Percutaneous Approach CODE: 3E0C705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening CODE: 3E0C70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Eye, Via Natural or Artificial Opening CODE: 3E0CX05 CODE DESCRIPTION: Introduction of Other Antineoplastic into Eye, External Approach CODE: 3E0CX0M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Eye, External Approach CODE: 3E0D305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach CODE: 3E0D30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Mouth and Pharynx, Percutaneous Approach CODE: 3E0D705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening CODE: 3E03002 CODE DESCRIPTION: Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach CODE: 3E0D70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Mouth and Pharynx, Via Natural or Artificial Opening CODE: 3E0DX05 CODE DESCRIPTION: Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach CODE: 3E0DX0M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Mouth and Pharynx, External Approach CODE: 3E0E305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach CODE: 3E0E30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Products of Conception, Percutaneous Approach CODE: 3E0E705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening CODE: 3E0E70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening CODE: 3E0E805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic CODE: 3E0E80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening Endoscopic CODE: 3E0F305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach CODE: 3E03003 CODE DESCRIPTION: Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach CODE: 3E0F30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Respiratory Tract, Percutaneous Approach CODE: 3E0F705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening CODE: 3E0F70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Respiratory Tract, Via Natural or Artificial Opening CODE: 3E0F805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic CODE: 3E0F80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Respiratory Tract, Via Natural or Artificial Opening Endoscopic CODE: 3E0G305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach CODE: 3E0G30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Upper GI, Percutaneous Approach CODE: 3E0G705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening CODE: 3E0G70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Upper GI, Via Natural or Artificial Opening CODE: 3E0G805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic CODE: 3E03005 CODE DESCRIPTION: Introduction of Other Antineoplastic into Peripheral Vein, Open Approach CODE: 3E0G80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Upper GI, Via Natural or Artificial Opening Endoscopic CODE: 3E0H305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach CODE: 3E0H30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Lower GI, Percutaneous Approach CODE: 3E0H705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening CODE: 3E0H70M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Lower GI, Via Natural or Artificial Opening CODE: 3E0H805 CODE DESCRIPTION: Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic CODE: 3E0H80M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Lower GI, Via Natural or Artificial Opening Endoscopic CODE: 3E0J305 CODE DESCRIPTION: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach CODE: 3E0J30M CODE DESCRIPTION: Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Percutaneous Approach CODE: 3E0J705 CODE DESCRIPTION: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening CODES: CODE DESCRIPTION: Injection or infusion of cancer chemotherapeutic substance CODE DESCRIPTION: Injection or infusion of biological response modifier [BRM] as an antineoplastic agent CODE: 00.10 CODE DESCRIPTION: Implantation of chemotherapeutic agent CODE: 00.15 CODE DESCRIPTION: High-dose infusion interleukin-2 [IL-2] CODE: 17.70 CODE DESCRIPTION: Intravenous infusion of clofarabine
MEASURE LIST

Immunocompromised Therapies (1067) NLM VALUE SETS (802.2)